Using TCGA RNA-seq data, we identified differentially edited 3’UTRs in breast cancers and experimentally validated editing sites in the 3’UTRs of MDM2, GINS1, and F11R regulated by ADAR1 with protein level implications. Here, MDM2 is linked to breast carcinoma.